Earlier this week, isobutanol producer Gevo raised $107 million in its initial public offering (IPO). The synthetic biology company sold approximately 7.1 million shares at $15 apiece, with shares trading as...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 (0) 20-3460840
For APAC (Singapore)